Now showing items 1-9 of 9
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398 | Grammen, C.; van den Mooter, G.; Appeltans, B.; Michiels, J.; Crucitti, T.; Ariën, K. K.; Augustyns, K.; Augustijns, P.; Brouwers, J. | International Journal of Pharmaceutics | 2014 | Article |
| Analysis of lipid levels and changes in body fat distribution in treatment-naïve, HIV-1-infected adults treated with rilpivirine of efavirenz over 96 weeks in the ECHO and THRIVE trials | Tebas, P.; Sension, M.; Arribas, J.; Duiculescu, D.; Florence, E.; Hung, C. C.; Wilkin, T.; Vanveggel, S.; Stevens, M.; Deckx, H. | Clinical Infectious Diseases | 2014 | Article |
| Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission | Ariën, K. K.; Venkatraj, M.; Michiels, J.; Joossens, J.; Vereecken, K.; Van der Veken, P.; Abdellati, S.; Cuylaerts, V.; Crucitti, T.; Heyndrickx, L.; Heeres, J.; Augustyns, K.; Lewi, P. J.; Vanham, G. | Journal of Antimicrobial Chemotherapy | 2013 | Article |
| Antiretroviral treatment in the private sector in Namibia | Van der Veen, F.; Mugala-Mukungu, F.; Kangudi, M.; Feris, A.; Katjitae, I.; Colebunders, R. | International Journal of STD & AIDS | 2011 | Article |
| Genotypic impact of prolonged detectable HIV-1 RNA viral load after HAART failure in a CRF01_AE infected cohort | Zolfo, M.; Schapiro, J.; Phan, V.; Koole, O.; Thai, S.; Vekemans, M.; Fransen, K.; Lynen, L. | AIDS Research and Human Retroviruses | 2011 | Article |
| Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor containing regimen | Conesa-Botella, A.; Florence, E.; Lynen, L.; Colebunders, R.; Menten, J.; Moreno-Reyes, R. | AIDS Research and Therapy | 2010 | Article-E |
| Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter] | Loutfy, M.; Ribera, E.; Florence, E.; De Wit, S.; Castagna, A.; Ryan, R.; Hill, A.; Vanaken, H.; van Delft, Y.; Marks, S. | Journal of Antimicrobial Chemotherapy | 2009 | Letter |
| Pediatric HIV infection: the state of antiretroviral therapy | McKellar, M. S.; Callens, S. F. J.; Colebunders, R. | Expert Review of Anti-infective Therapy | 2008 | Article |
| First-line antiretroviral therapy in Africa; how evidence-based are our recommendations? | Colebunders, R.; Kamya, M. R.; Laurence, J.; Kambugu, A.; Byakwaga, H.; Songa Mwebaze, P.; Muganzi Muganga, A.; Katwere, M.; Katabira, E.; Muganzi, A. | AIDS Reviews | 2005 | Article |
Now showing items 1-9 of 9